Alembic Pharmaceuticals Limited (APLLTD)
ISIN: INE901L01018 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
749.2
-1.1(-0.15%)

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (API) and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, anti-diabetic, gynecology, acute, gastroenterology, ophthalmology, dermatology, nephrology/urology, orthopedics, cancer, inflammation, autoimmune diseases, anti-infective, cold and cough, and metabolic disorders, as well as hospital care and animal health. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Pricing Updates

TODAY'S HIGH

754.95

TODAY'S LOW

733.2

52 WEEK HIGH

1025.95

52 WEEK LOW

678.3

Major Holders

% of Shares Held by
All Insider

70.27%

% of Shares Held by
Institutions

14.49%

% of Float Held by
Institutions

48.74%

Number of Institutions
Holding Shares

52

Company Overview

MARKET CAP

14726.50 Cr.

ETERPRISE VALUE

15880.18 Cr.

NO. OF SHARES

19.65 Cr.

BOOK VALUE

263.824

DIV. YIELD

14%

DEBT

941.50 Cr.

GROSS PROFIT

4052.91 Cr.

CASH

335.48 Cr.

REVENUE

5170.42 Cr.

REVENUE/SHARE

263.069

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-186.10 Cr.-186.10 Cr.-14.36 Cr.-14.36 Cr.
Change To Liabilities45.27 Cr.-21.11 Cr.-50.31 Cr.258.84 Cr.
Total cashflows from Investing Activities-838.81 Cr.-731.63 Cr.-755.60 Cr.-884.38 Cr.
Net Borrowings-1258.47 Cr.591.90 Cr.220.66 Cr.619.05 Cr.
Total Cash from Financing Activities-597.43 Cr.154.85 Cr.59.04 Cr.502.63 Cr.
Other Liabilities-18.04 Cr.6.80 Cr.359.01 Cr.-154.33 Cr.
Total Assets734.08 Cr.734.08 Cr.734.08 Cr.734.08 Cr.
Net Income1178.11 Cr.828.82 Cr.584.37 Cr.412.63 Cr.
Change in Cash26.22 Cr.-127.23 Cr.115.33 Cr.-69.34 Cr.
Effect of Exchange Rate-93 Lakhs41 Lakhs-7 Lakhs-7 Lakhs
Total Cash from Operating Activities1463.38 Cr.449.13 Cr.811.96 Cr.312.42 Cr.
Depreciation183.47 Cr.156.89 Cr.114.81 Cr.105.31 Cr.
Other Cashflows from Investing Activities6.53 Cr.2.66 Cr.21.85 Cr.1.38 Cr.
Dividends Paid0-235.64 Cr.-75.41 Cr.-75.42 Cr.
Change to Inventory-298.62 Cr.-220.27 Cr.-233.33 Cr.-101.18 Cr.
Change to Account Receivables510.93 Cr.-358.26 Cr.36.19 Cr.-184.18 Cr.
Other Cashflows from Financing Activities-73.04 Cr.-144.85 Cr.-86.21 Cr.-41 Cr.
Change to Net Income-137.74 Cr.56.26 Cr.1.22 Cr.-24.67 Cr.
Capital Expenditures-659.51 Cr.-734.89 Cr.-653.93 Cr.-749.36 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax1399.82 Cr.999.88 Cr.740.04 Cr.533.17 Cr.
Minority Interest-60.64 Cr.-28.96 Cr.-79 Lakhs31 Lakhs
Net Income1296.82 Cr.1111.41 Cr.741.32 Cr.509.98 Cr.
Selling General Administrative1053.03 Cr.908.96 Cr.764.02 Cr.637.11 Cr.
Gross Profit4052.91 Cr.3515.31 Cr.2903.68 Cr.2214.15 Cr.
Ebit1296.82 Cr.1111.41 Cr.741.32 Cr.509.98 Cr.
Operating Income1296.82 Cr.1111.41 Cr.741.32 Cr.509.98 Cr.
Other Operating Expenses1519.64 Cr.1337.80 Cr.1270.28 Cr.961.68 Cr.
Interest Expense-16.02 Cr.-27.16 Cr.-18.41 Cr.-3.40 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense253.32 Cr.199.18 Cr.156.75 Cr.120.35 Cr.
Total Revenue5393.12 Cr.4605.75 Cr.3934.68 Cr.3130.18 Cr.
Total Operating Expenses4096.30 Cr.3494.34 Cr.3193.36 Cr.2620.20 Cr.
Cost of Revenue1340.21 Cr.1090.44 Cr.1031 Cr.916.03 Cr.
Total Other Income Expense Net103 Cr.-111.53 Cr.-1.28 Cr.23.19 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.1146.50 Cr.800.70 Cr.583.29 Cr.412.82 Cr.
Net Income Applicable to Common Shares1178.11 Cr.828.82 Cr.584.37 Cr.412.63 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets322.94 Cr.299.02 Cr.266.26 Cr.161.98 Cr.
Capital Surplus748.39 Cr.000
Total Liabilities1642.01 Cr.2798.60 Cr.2059.76 Cr.1720.60 Cr.
Stock Holder Equity5127.61 Cr.3219.41 Cr.2718.82 Cr.2220.14 Cr.
Minority Interest-60.64 Cr.-28.96 Cr.-79 Lakhs31 Lakhs
Other Liabilities116.72 Cr.128.64 Cr.108.90 Cr.47.05 Cr.
Total Assets6708.98 Cr.5989.05 Cr.4777.79 Cr.3941.05 Cr.
Common Stock39.31 Cr.37.70 Cr.37.70 Cr.37.70 Cr.
Retained Earnings4194.11 Cr.3074.95 Cr.2623.36 Cr.2174.12 Cr.
Other Liabilities89.74 Cr.86.71 Cr.70.80 Cr.76.21 Cr.
Good Will003.61 Cr.3.77 Cr.
Treasury Stock145.80 Cr.106.76 Cr.57.76 Cr.8.32 Cr.
Other Assets110.81 Cr.110.66 Cr.61.59 Cr.71.14 Cr.
Cash98.06 Cr.71.84 Cr.199.07 Cr.83.74 Cr.
Current Liabilities1280.84 Cr.1751.60 Cr.1489.66 Cr.1144.39 Cr.
Long Term Asset Charges0000
Short Long Term Debt299.88 Cr.0200 Cr.0
Other Stockholder Equity145.80 Cr.106.76 Cr.57.76 Cr.8.32 Cr.
Property Plant Equipment3648.02 Cr.3099 Cr.2439.81 Cr.1837.78 Cr.
Total Cur. Assets2577.90 Cr.2462.75 Cr.1957.76 Cr.1824.74 Cr.
Long Term Investments49.31 Cr.17.62 Cr.48.76 Cr.41.64 Cr.
Net Tangible Assets4804.67 Cr.2920.39 Cr.2448.95 Cr.2054.39 Cr.
Short Term Investments186.97 Cr.000
Net Receivables365.18 Cr.895.73 Cr.488.92 Cr.529.79 Cr.
Long Term Debt199.89 Cr.886.99 Cr.499.30 Cr.500 Cr.
Inventory1486.15 Cr.1187.53 Cr.967.26 Cr.733.93 Cr.
Accounts Payable668.77 Cr.625.93 Cr.644.34 Cr.759.32 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account